Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype

Journal of Medicinal Chemistry

Volumn 39, Issue 21, 1996, Pages 4142-4148

  Kim, Yong Chul ^a   Ji, Xiao Duo ^a   Jacobson, Kenneth A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; TRIAZOLOQUINAZOLINE DERIVATIVE;

ACYLATION; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; NONHUMAN; RADIOASSAY; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ADENOSINE; AFFINITY LABELS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CELL LINE; CEREBRAL CORTEX; CORPUS STRIATUM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; QUINAZOLINES; RATS; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TRIAZOLES;

EID: 0029842517     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960482i     Document Type: Article

References (29)

1. Olah, M. E.; Stiles, G. L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 581-606.
2. 3 receptors - pharmacological properties, species -differences and receptor functions. Trends Pharmacol. Sci. 1994, 75, 298-306.
3. 3 adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 1995, 20, 689-699.
4. 3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 1995, 115, 945-952.
5. 3 receptor activation in rats. Eur. J. Pharmacol. 1998, 298, 293-297.
6. 3-adenosine receptors: Mediation of behavioral depressant effects. FEBS Lett. 1993, 336, 57-60.
7. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 1994, 263, 59-67.
8. 3 receptor agonists. Biochem. Biophys. Res. Commun. 1996, 219, 904-910.
9. 3 adenosine receptors. J. Med. Chem. 1994, 37, 3373-3382.
10. 3-adenosine receptor. Mol. Pharmacol. 1994, 45, 1101-1111.
11. Siddiqi, S. M.; Ji, X. D.; Melman, N.; Olah, M. E.; Jain, R.; Evans, P.; Glashofer, M.; Padgett, W. L.; Cohen, L. A.; Daly, J. W.; Stiles, G. L.; Jacobson, K. A. A survey of non-xanthine derivatives as adenosine receptor ligands. Nucleoside Nucleotide 1996, 15, 693-718.
12. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. Adenosine receptors-pharmacology, structure activity relationships, and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
13. 1 adenosine receptor antagonist in the guineapig heart and brain and in DDT(1)MF-2 cells. J. Pharmacol. Exp. Ther. 1995, 275, 1167-1176.
14. 2a adenosine receptor antagonists. Curr. Med. Chem. 1995, 2, 707-722.
15. van Rhee, A. M.; Siddiqi, S. M.; Melman, N.; Shi, D.; Padgett, W. L.; Daly, J. W.; Jacobson, K. A. Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists. J. Med. Chem. 1996, 39, 398-406.
16. Ji, X. D.; Melman, N.; Jacobson, K. A. Interactions of flavonoids and other phytochemicals with adenosine receptors. J. Med. Chem. 1996, 39, 781-788.
17. 3 adenosine receptor antagonists. J. Med. Chem. 1996, 39, 2293-2301.
18. 3 receptors. J. Med. Chem. 1996, 39, 2980-2989.
19. Francis, J. E.; Cash, W. D.; Psychoyos, S.; Ghai, G.; Wenk, P.; Friedmann, R. C.; Atkins, C.; Warren, V.; Furness, P.; Hyun, J. L. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists. J. Med. Chem. 1988, 31, 1014-1020.
20. 1 receptor in the rat cortex. Mol. Pharmacol. 1991, 39, 49-54.
21. 2-adenosine receptors using radioligand binding and photoaffinity labeling. J. Recept. Res. 1992, 12, 149-169.
22. 6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1980, 313, 179-187.
23. 2 receptors in rat brain tissue. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
24. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
25. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978-982.
26. 3-adenosine receptors, Drug Dev. Res. 1994, 33, 51-59.
27. 50) of an enzyme reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
28. 2A adenosine receptors. J. Biol. Chem. 1995, 270, 20485-20490.
29. 2A adenosine receptor are required for ligand recognition. Mol. Pharmacol. 1996, 49, 683-691.